Literature DB >> 27615359

Papillary Thyroid Carcinoma: A Malignant Tumor with Increased Antioxidant Defense Capacity.

Branislav R Rovcanin1, Kristina R Gopcevic, Dusan Lj Kekic, Vladan R Zivaljevic, Aleksandar Dj Diklic, Ivan R Paunovic.   

Abstract

Papillary thyroid carcinoma (PTC) is the commonest thyroid malignancy worldwide for which the radiation exposure is the most influential risk factor. The levels of oxidative stress in PTC are not well characterized on the tissue level. The objective of this study was to evaluate total oxidant status (TOS) and total antioxidant status (TAS) in PTC and benign goiter (BG) tissues and to examine their association with clinicopathological characteristics. Tumor and normal thyroid tissue samples were collected from 59 PTC patients, and goiter tissues were collected from 50 BG patients. TOS and TAS were quantified in the tissue homogenates by spectrophotometric assays. TOS values in tumor tissues did not differ significantly from normal and goiter tissues; however, PTC tissues have significantly higher TAS values than normal and goiter tissues. TOS values correlated with retrosternal growth in BG patients. The significant correlations were found between TOS and TAS values and thyroid function parameters. In 17 PTC patients with multiple tumor foci (multicentric phenotype), TAS values were significantly lower, compared to 42 patients with unicentric PTC. TAS and TOS are the most useful predictors of thyroid capsular invasion by PTC. The age, sex, body mass index, smoking, familial history of thyroid disease and nodule size did not influence TOS and TAS in PTC or BG patients. In conclusion, we show the profiles of TOS and TAS in PTC and BG tissues. Importantly, PTC tissues possess increased antioxidant capacity. The redox status influences the parameters of the thyroid function and tumor's biological behavior.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27615359     DOI: 10.1620/tjem.240.101

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  4 in total

Review 1.  Metabolic Alterations of Thyroid Cancer as Potential Therapeutic Targets.

Authors:  Domenico Ciavardelli; Maria Bellomo; Ada Consalvo; Caterina Crescimanno; Veronica Vella
Journal:  Biomed Res Int       Date:  2017-11-06       Impact factor: 3.411

2.  Contribution of Glycation and Oxidative Stress to Thyroid Gland Pathology-A Pilot Study.

Authors:  Aleksandra Kuzan; Emilia Królewicz; Karolina Nowakowska; Kamilla Stach; Krzysztof Kaliszewski; Paweł Domosławski; Łukasz Kotyra; Andrzej Gamian; Irena Kustrzeba-Wójcicka
Journal:  Biomolecules       Date:  2021-04-10

3.  Redox metabolism correlates with cellular turnover and clinical phenotype of papillary thyroid carcinoma and colloid goiter.

Authors:  Branislav Rovcanin; Kristina Gopcevic; Dusan Kekic; Vladan Zivaljevic; Aleksandar Diklic; Svetislav Tatic; Milan Jovanovic; Bozidar Odalovic; Ivan Paunovic
Journal:  Arch Med Sci       Date:  2019-10-07       Impact factor: 3.707

Review 4.  The Epithelial-Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression.

Authors:  Monica Fedele; Riccardo Sgarra; Sabrina Battista; Laura Cerchia; Guidalberto Manfioletti
Journal:  Int J Mol Sci       Date:  2022-01-12       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.